(Approval lapsed 5/6/2020) CARBIDOPA and LEVODOPA TABLETS, USP 25mg/250mg carbidopa/levodopa tablet bottle
Section 19A approved medicine
(Approval lapsed 5/6/2020) CARBIDOPA and LEVODOPA TABLETS, USP 25mg/250mg carbidopa/levodopa tablet bottle
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Lapsed
Medicines in short supply/unavailable
SINEMET 250/25 levodopa/carbidopa 250mg/25mg tablet bottle - ARTG 171666
Indication(s)
- Indicated for the treatment of Parkinson's disease and syndrome. It is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia.
- Frequently helpful in the management of tremor, dysphagia, sialorrhoea and postural instability associated with Parkinson's disease and syndrome.